← Volver atrás
Publicaciones

Pathogenic variants in the autophagy-tethering factor EPG5 drive neurodegeneration through mitochondrial dysfunction and innate immune activation.

Autores

Singh, Kritarth , Dafsari, Hormos Salimi , Gillham, Olivia , Chi, Haoyu , Mandzhukova, Ivet , Kourouzidou, Ioanna , Sheshadri, Preethi , Chung, Chih-Yao , PINGITORE, VALERIA, Vansenne, Fleur , Selwood, David L , Pendin, Diana , Szabadkai, Gyorgy , Fanto, Manolis , Jungbluth, Heinz , Duchen, Michael R

Publicación externa

No

Medio

Nat. Commun.

Alcance

Article

Naturaleza

Científica

Cuartil JCR

1

Cuartil SJR

1

Fecha de publicacion

01/01/2026

ISI

001827715100003

Scopus Id

2-s2.0-105045273011

Abstract

The autophagy-tethering factor ectopic P-granule 5 autophagy protein (EPG5) plays a key role in autophagosome-lysosome fusion. Impaired autophagy associated with pathogenic variants in EPG5 causes a rare devastating multisystem disorder known as Vici syndrome, which features neurodevelopmental defects, severe progressive neurodegeneration and immunodeficiency. The pathophysiological mechanisms driving disease presentation and progression are only partially understood. In patient-derived fibroblasts and iPS cells differentiated to cortical neurons, we find that impaired mitophagy leads to mitochondrial bioenergetic dysfunction. Physiological cytosolic Ca(2+) transients result in unexpected mitochondrial Ca(2+) overload despite a decrease in mitochondrial membrane potential. This is attributed to downregulation of MICU1. Ca(2+) signals cause mitochondrial depolarisation, mtDNA release and activation of the cGAS-STING pathway, reversed by pharmacological inhibition of the mitochondrial permeability transition pore (mPTP) or of the STING pathway. Thus, we identify a pathophysiological cascade driving disease progression associated with EPG5 deficiency, including impaired mitochondrial bioenergetics, mitochondrial Ca(2+) overload, vulnerability to mPTP opening and activation of innate immune signalling, signposting multiple potential therapeutic targets.

Palabras clave

Absent corpus callosum cataract immunodeficiency; Agenesis of Corpus Callosum; Animals; Autophagy; Calcium; Calcium-Binding Proteins; Cataract; cGAS-STING Signaling Pathway; DNA, Mitochondrial; Fibroblasts; Humans; Immunity, Innate; Membrane Potential, Mitochondrial; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitophagy; Neurodegenerative Diseases; Neurons; STING Protein; acetyl coenzyme A; actin; aequorin; autophagy related protein; calcium ion; caspase; citrate synthase; cytochrome c; digitonin; ectopic p granule 5 autophagy protein; glutamic acid; interferon; interferon regulatory factor; interferon regulatory factor 3; messenger RNA; mitochondrial DNA; mitochondrial permeability transition pore; oxoglutarate dehydrogenase; pyruvate dehydrogenase; pyruvic acid; reactive oxygen metabolite; reduced nicotinamide adenine dinucleotide; reduced nicotinamide adenine dinucleotide dehydrogenase (ubiquinone); STAT1 pr